Cytonus Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Cytonus Therapeutics's estimated annual revenue is currently $2.6M per year.
- Cytonus Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Cytonus Therapeutics has 17 Employees.
- Cytonus Therapeutics grew their employee count by 6% last year.
Cytonus Therapeutics's People
| Name | Title | Email/Phone |
|---|
Cytonus Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Cytonus Therapeutics?
Cytonus Therapeutics Inc. is a San Diego-based biotech company that has developed a vast platform of proprietary immunotherapeutic products to treat a wide range of medical conditions including cancers, infectious diseases, inflammatory diseases and cognitive disorders, and to improve patient outcomes. Its proprietary Cargocyteâ„¢ technologies are next-generation Biomolecular Delivery Transporterâ„¢ which have numerous medical applications across unmet therapeutic areas. Cargocytesâ„¢ are engineered to safely transport a multiplicity of therapeutic payloads into difficult-to-reach targeted tissues, and can be programmed to deliver selective, potent, and controllable allogeneic therapies.
keywords:N/A
N/A
Total Funding
17
Number of Employees
$2.6M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.8M | 17 | 6% | $21.4M |
#2 | $3.6M | 17 | N/A | N/A |
#3 | $1.5M | 17 | N/A | N/A |
#4 | $1.5M | 17 | N/A | N/A |
#5 | $1.5M | 17 | N/A | N/A |